Maxiliv Injection contains Glutathione 600mg and is indicated for use as an antioxidant and detoxifying agent in various clinical conditions. Glutathione is a tripeptide composed of glutamine, cysteine, and glycine, playing a critical role in cellular protection against oxidative stress by neutralizing free radicals and reactive oxygen species. Maxiliv Injection is commonly utilized in the management of liver disorders including chronic hepatitis, alcoholic liver disease, and drug-induced hepatotoxicity, where it aids in restoring hepatic function and promoting detoxification. Additionally, it supports immune function and may be employed as an adjunct therapy in conditions associated with oxidative damage such as neurodegenerative diseases and certain metabolic disorders. The injectable formulation ensures rapid bioavailability and is administered under medical supervision, typically via intravenous or intramuscular routes. Dosage and duration of therapy should be individualized based on the patient’s clinical condition and response. Caution is advised in patients with known hypersensitivity to glutathione or any component of the formulation. Adverse effects are generally rare but may include mild allergic reactions. Maxiliv Injection should be used as part of a comprehensive treatment plan and not as a sole therapy.